Retrospective evaluation of MR-guided pancreatic radiotherapy (RAMP)

Retrospective evaluation of MR-guided pancreatic radiotherapy (RAMP) - RAMP

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00040696

Enrollment

200

Registered

2026-06-18

Start date

2026-04-01

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C25

Interventions

Group 1: Treatment at the individual centers is carried out according to clinical standards. Only the resulting data are forwarded for analysis.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with PDAC treated with MRgRT

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Local control	—

Secondary

Measure	Time frame
-Distant metastasis-free survival -Disease-free survival -Disease-specific survival -Overall survival -Acute and late toxicity according to CTCAE version 5.0	—

Countries

Germany, Italy, Switzerland

Contacts

Public ContactPaul Rogowski

Klinikum der LMU München

paul.rogowski@med.uni-muenchen.de+4989440076763

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 29, 2026